EP 4263588 A1 20231025 - DSG2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF COVID-19
Title (en)
DSG2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF COVID-19
Title (de)
DSG2-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON COVID-19
Title (fr)
COMPOSITIONS DE DSG2 ET PROCÉDÉS POUR LE TRAITEMENT DE LA COVID-19
Publication
Application
Priority
- US 202063125583 P 20201215
- US 202163274715 P 20211102
- US 2021063433 W 20211215
Abstract (en)
[origin: WO2022132854A1] The disclosure generally relates to compositions and methods of treating COVID-19 by administering compositions disclosed herein. The methods also include the treatment of post-COVID-19 syndrome and cardiomyopathies using compositions described in the present disclosure.
IPC 8 full level
C07K 14/705 (2006.01); A61K 38/17 (2006.01); A61P 9/00 (2006.01); A61P 11/00 (2006.01)
CPC (source: EP IL KR)
A61K 38/00 (2013.01 - IL); A61P 9/02 (2018.01 - EP IL KR); C07K 14/705 (2013.01 - EP IL KR); A61K 38/00 (2013.01 - EP KR); C07K 2319/30 (2013.01 - EP IL KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022132854 A1 20220623; AU 2021400845 A1 20230713; CA 3202364 A1 20220623; EP 4263588 A1 20231025; IL 303444 A 20230801; JP 2024500250 A 20240105; KR 20230120141 A 20230816; MX 2023006704 A 20230620; TW 202237634 A 20221001
DOCDB simple family (application)
US 2021063433 W 20211215; AU 2021400845 A 20211215; CA 3202364 A 20211215; EP 21841114 A 20211215; IL 30344423 A 20230605; JP 2023560254 A 20211215; KR 20237024240 A 20211215; MX 2023006704 A 20211215; TW 110146991 A 20211215